Targeting GIP and GLP-1 to Individualize Treatment in Patients With T2DM and Obesity [super slim keto gummies 5x]

Targeting GIP and GLP-1 to Individualize Treatment in Patients With T2DM and Obesity [super slim keto gummies 5x]

| 1h 28m 28s | Video has closed captioning.

Chair, Javier Morales, MD, FACP, FACE, Juan Pablo Frías, MD, and Donna H. Ryan, MD, FTOS, discuss T2DM and obesity in this CME activity titled “Is Synergism the Secret to Success? Candid Conversations on Targeting GIP and GLP-1 to Individualize Treatment in Patients With T2DM and Obesity.” For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/KZF865. CME credit will be available until May 7, 2023.